Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, ...

Stocks of MRNA, PFE, NVAX and BNTX rose in anticipation that a new virus in China could trigger another pandemic.

B. Riley decreased their FY2024 earnings estimates for Novavax in a report issued on Thursday, February 20th. B. Riley ...

Unusual total active option classes on open include: Opko Health ( OPK ), Chewy ( CHWY ), Mini SPX (.XSP), EFA (EFA), Novavax ( NVAX ), B Riley Financial ( RILY ), Pinduoduo ( PDD ), Lucid Group ( ...

Bullish option flow detected in Novavax (NVAX) with 23,789 calls trading, 3x expected, and implied vol increasing over 8 points to 114.25%.

Virologists warn the pathogen should be monitored ‘very, very carefully’ because it attacks human cells in the same way as ...

Novavax NVAX is expected to report fourth-quarter and full-year 2024 earnings later this month. In the last reported quarter, the company’s earnings beat estimates by 12.64%. The Zacks Consensus ...

Novavax (NVAX) ended the recent trading session at $7.92, demonstrating a -1.25% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.43%.

Chinese technology stocks slumped as the country’s economy worsened. That changed when U.S. tariffs against China fell to ...

Shares of Novavax Inc. NVAX slipped 1.25% to $7.92 Thursday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.47% to 19,962.

Novavax Inc. closed 66.14% below its 52-week high of $23.86, which the company reached on June 6th.